Physics – Medical Physics
Scientific paper
Jan 1999
adsabs.harvard.edu/cgi-bin/nph-data_query?bibcode=1999aipc..458..239m&link_type=abstract
Space technology and applications international forum -1999. AIP Conference Proceedings, Volume 458, pp. 239-244 (1999).
Physics
Medical Physics
Aerospace Bio- And Medical Physics
Scientific paper
The International Space Station (ISS) is the linch-pin of NASA's future space plans. It emphasizes scientific research by providing a world-class scientific laboratory in which to perform long-term basic science experiments in the space environment of microgravity, radiation, vacuum, vantage-point, etc. It will serve as a test-bed for determining human system response to long-term space flight and for developing the life support equipment necessary for NASA's Human Exploration and Development of Space (HEDS) enterprise. The ISS will also provide facilities (up to 30% of the U.S. module) for testing material, agricultural, cellular, human, aquatic, and plant/animal systems to reveal phenomena heretofore shrouded by the veil of 1-g. These insights will improve life on Earth and will provide a commercial basis for new products and services. In fact, some products, e.g., rare metal-alloys, semiconductor chips, or protein crystals that cannot now be produced on Earth may be found to be sufficiently valuable to be manufactured on-orbit. Biotechnology, pharmaceutical and biomedical experiments have been regularly flown on 10-16 day Space Shuttle flights and on three-month Mir flights for basic science knowledge and for life support system and commercial product development. Since 1985, NASA has created several Commercial Space Centers (CSCs) for the express purpose of bringing university, government and industrial researchers together to utilize space flight and space technology to develop new industrial products and processes. BioServe Space Technologies at the University of Colorado at Boulder and Kansas State University, Manhattan, Kansas, is such a NASA sponsored CSC that has worked with over 65 companies and institutions in the Biotech Sector in the past 11 years and has successfully discovered and transferred new product and process information to its industry partners. While tests in the space environment have been limited to about two weeks on Shuttle or a few months on Mir, tests on ISS can be performed over many months, or even years. More importantly, a test can be regularly scheduled so that the effects of microgravity and other space environment parameters can be thoroughly researched and quantified. This paper attempts to envision the potential benefits of this soon-to-be-available orbital laboratory and the broad commercial utilization of ISS that will likely occur.
Morgenthaler George W.
Stodieck Louis
No associations
LandOfFree
Potential commercial use of the International Space Station by the biotechnology/pharmaceutical/biomedical sector does not yet have a rating. At this time, there are no reviews or comments for this scientific paper.
If you have personal experience with Potential commercial use of the International Space Station by the biotechnology/pharmaceutical/biomedical sector, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potential commercial use of the International Space Station by the biotechnology/pharmaceutical/biomedical sector will most certainly appreciate the feedback.
Profile ID: LFWR-SCP-O-1188172